Vitamin D for Women: Dosing From Pregnancy to Menopause

By Erin Rose · Published September 14, 2026 · Reviewed against primary sources · Methodology · About Us

Informational summary of NIH guidance and published trials, not medical advice. In pregnancy and while breastfeeding, the clinician managing your care has the final say on any dose.

Know your level already? See the best vitamin D picks at that dose →

The dose table for women, by life stage

Source: NIH Office of Dietary Supplements. If your label or lab report uses micrograms, 600 IU is 15 mcg and 4,000 IU is 100 mcg — the conversion chart covers every dose.

Who is actually low: the deficiency peak is in the reproductive years, not after 65

The intuition is that older women are the ones short of vitamin D. The blood data say the opposite. In CDC NHANES measurements, the share of women with serum 25(OH)D below 50 nmol/L (20 ng/mL) is highest at 18–30 and falls with every age band, most likely because older women are the ones already taking a supplement.

The national survey that uses a stricter cut-point tells the same story. Using serum 25(OH)D below 30 nmol/L as “at risk of deficiency”, NHANES 2011–2014 found the highest prevalence among adults aged 20–39 (7.6%) and the lowest among adults 60 and over (2.9%); it was far higher among non-Hispanic Black Americans (17.5%) than non-Hispanic white Americans (2.1%), and lower in people who used a supplement (Herrick et al., 2019, PMID 31076739). The two figures above differ because they use different cut-points, 50 versus 30 nmol/L; the shape by age is the same in both.

What raises the odds regardless of age: darker skin, obesity, little time outdoors, a covering dress code, malabsorption, and the drug interactions listed on the deficiency-signs page. What does not, on the evidence: being a woman rather than a man. In the same NHANES data the sexes differ by a couple of points, not by a category.

Pregnancy: what changed in 2024

For a decade the official position was cautious. ACOG’s committee opinion did not recommend screening every pregnant woman, considered testing when risk was elevated, said that when a deficiency is found 1,000–2,000 IU/day is regarded as safe, and noted that higher regimens had not been studied in pregnancy (PMID 21691184).

In 2024 the Endocrine Society moved. Its clinical practice guideline suggests empiric vitamin D supplementation during pregnancy (intake above the Dietary Reference Intake, without testing first) because of its potential to lower the risk of preeclampsia, intrauterine mortality, preterm birth, small-for-gestational-age birth and neonatal mortality. The same guideline says plainly that because trial doses varied so much, the optimal dose remains unclear, and it suggests against routine 25(OH)D testing in pregnancy (PMID 38828931). Pregnancy is one of only four groups the guideline singles out this way; healthy adults under 75 are told not to exceed the RDA for disease prevention.

The trials behind that: the Cochrane review (30 trials, 7,033 women overall; 22 trials and 3,725 women in the vitamin-D-alone comparison) found that vitamin D alone during pregnancy probably reduces the risk of preeclampsia (RR 0.48; 4 trials, 499 women), gestational diabetes (RR 0.51; 4 trials, 446 women) and low birthweight (RR 0.55; 5 trials, 697 women), all moderate-certainty evidence from small trial pools, and may make little or no difference to preterm birth (PMID 31348529). The safety trial everyone cites randomized 494 women from 12–16 weeks to 400, 2,000 or 4,000 IU of D3 a day until delivery: the 4,000 IU group was the most likely to reach sufficiency, 4,000 was not significantly better than 2,000 on that measure, and not a single adverse event was attributed to vitamin D at any dose (PMID 21706518). And the MAVIDOS trial, which gave 1,000 IU/day from 14–17 weeks, found the children of supplemented mothers had higher whole-body bone mineral density at ages 6–7 (PMID 39306330).

The practical range, then, is 1,000–2,000 IU/day on top of food, with 4,000 IU/day as the ceiling that has been tested in pregnancy. Every one of those numbers is a conversation with the person managing the pregnancy. Which raises the question of what a prenatal actually contains.

Breastfeeding: the dose question is the baby’s

Breast milk carries little vitamin D at ordinary maternal intakes, which is why the American Academy of Pediatrics recommends 400 IU/day for all breastfed infants from the first days of life (PMID 18977996). The mother’s own RDA stays at 600 IU.

A randomized trial tested the alternative. Exclusively breastfeeding mothers took 400, 2,400 or 6,400 IU/day for six months; infants in the 400 IU arm got 400 IU drops, infants in the other arms got placebo. The 2,400 IU arm was stopped early because too many of those infants became deficient. At 6,400 IU/day, the mother’s milk alone kept her infant’s vitamin D level equal to the infants who received drops, with no maternal safety signal (PMID 26416936). The finding rests on the 95 of 334 enrolled pairs still fully breastfeeding at 7 months, a small completing group. It works, and it is also above the 4,000 IU adult upper limit. It was a monitored trial dose. That makes it a choice to make with your pediatrician rather than a default.

We read 444 prenatal labels: what a prenatal actually carries

Original research Every on-market supplement label filed with the NIH Dietary Supplement Label Database whose product name contains “prenatal” (808 on the market, 808 read, 444 confirmed prenatals, 391 carrying a vitamin D row), with the vitamin D per day taken from the Supplement Facts panel and the label’s own maximum daily servings. Micrograms converted at 40 IU/mcg.

72.1% of prenatals carry less than 1,000 IU of vitamin D a day. The bottom quarter of labels carry 400 IU or less and the top quarter 1,000 IU or more. 27.9% reach 1,000 IU, 7.7% reach 2,000 IU, and 2.6% reach the 4,000 IU/day that the pregnancy safety trial found most effective. 96.6% of labels that state a form use D3. The shelf is really two shelves: a large block of older formulas at exactly 400 IU and a newer block at 800–1,000 IU. The median sits on the boundary between them, which is why we do not publish one: it moved from 400 to 600 IU between the two halves of our read and failed our own validation rule.

Set that next to the trials. The guideline now suggests going above the RDA in pregnancy; the trial that established safety used 4,000 IU; and the product designed for pregnancy carries, on 72.1% of labels, less than a quarter of that, with a quarter of labels at 400 IU or less, under the RDA itself. A prenatal is built to deliver folate and iron (86.7% of these labels carry folate and 74.5% iron). Vitamin D rides along at whatever dose was standard when the label was written. If you want to be in the trial-supported range, the prenatal usually has to be topped up, and the top-up is the conversation to have at your next appointment.

For contrast, the standalone vitamin D shelf runs the other way. In our separate census of 250 vitamin D labels, the median daily directed dose was 2,000 IU, the 90th percentile 5,000 IU, and 56 of 239 labels directed a daily amount at or above the 4,000 IU upper limit. A pregnant woman who grabs a D3 bottle at random can land above the limit as easily as a prenatal leaves her short of the trial dose. The 1,000 vs 5,000 IU guide covers which is which.

Method: 808 labels retrieved from the NIH Dietary Supplement Label Database (DSLD) v9 on 2026-09-14 for the term “prenatal”; 444 carry the word in the product name and are on the market; 391 declare vitamin D with a parseable quantity. Vitamin D per day is the panel quantity for the labelled serving multiplied by the maximum daily servings the label directs; mcg converted at 40 IU/mcg. Percentages are stated against labels that declared vitamin D, never against labels read. The corpus includes prescription-only prenatals (the CitraNatal line alone is several dozen labels) alongside retail products, and we did not separate them; a prescription prenatal is not something this site can link to. Every figure was recomputed in both halves of the read order: 11 of 13 findings held within tolerance; the two that did not (the median and the share below the 600 IU RDA) are deliberately not published as numbers. The figures are published as open data at /vitamin-d/for-women.json (CC BY 4.0). What it cannot tell you: which prenatals sell most, whether a label’s figure matches what is in the tablet, or anything about products not filed with the NIH.

Perimenopause and after: what vitamin D can and cannot do for bone

Bone is where women’s vitamin D questions get most urgent and where the evidence is most sobering. The Women’s Health Initiative randomized 36,282 postmenopausal women to 400 IU of D3 plus 1,000 mg of calcium or placebo for an average of seven years: hip bone density was 1.06% higher in the supplemented group, hip fractures fell but not significantly (hazard ratio 0.88, 95% CI 0.72–1.08), and kidney stones rose 17% (PMID 16481635). VITAL gave 2,000 IU/day to 25,871 adults, half of them women 55 and older, who were not recruited for low vitamin D or low bone mass, and found no effect on total, non-vertebral or hip fractures over 5.3 years (PMID 35939577). The US Preventive Services Task Force concluded that 400 IU or less of vitamin D with 1,000 mg or less of calcium has no benefit for primary fracture prevention in community-dwelling postmenopausal women, and that the evidence for higher doses is inadequate to judge (PMID 29677309).

The one result that runs the other way is dose-dependent: a meta-analysis of 12 double-blind trials in adults 65 and over found that pooling only the trials whose participants actually received more than 400 IU/day gave a 20% reduction in non-vertebral fractures (RR 0.80, 95% CI 0.72–0.89) and 18% in hip fractures, an effect that grew with dose and achieved blood level and was independent of calcium (PMID 19307517). The reading this site gives everywhere applies here too: vitamin D is a correction supplement, not a preventive one. Every null trial gave it to women who already had enough. If you test low, correcting it matters for bone. If you don’t, more vitamin D is not the lever; calcium intake, resistance and impact exercise, and the bone-density conversation with your clinician are. The calcium dosage guide and the K2 question pick up from here. This page makes no claim about vitamin D and menopausal symptoms, because there is no trial we would stand behind.

The limit is 4,000 IU whether or not you are pregnant

The tolerable upper limit for adults, pregnant and breastfeeding women included, is 4,000 IU (100 mcg) a day of sustained intake. The one dose above it on this page, the 6,400 IU in the lactation trial, was a monitored trial dose. The 50,000 IU capsule your doctor may prescribe is taken weekly, not daily, for a defined number of weeks to correct a tested deficiency; it is not a supplement to keep taking. D3 (cholecalciferol) beats D2 at any stage because it raises blood levels more reliably (why). And if you take a prenatal, a multivitamin and a standalone D3, add the three numbers before you add a fourth.

Testing: when it is worth it

A 25-hydroxyvitamin D [25(OH)D] test is reliable and widely available: below 20 ng/mL is deficient, 20–29 ng/mL insufficient, and 30–80 ng/mL adequate. The 2024 Endocrine Society guideline suggests against routine testing in the general population and in pregnancy, on the grounds that the trials showing benefit did not test first; ACOG considers a test reasonable when risk is elevated. The practical rule: test if you are in a higher-risk group, before starting any correction-level dose, and 8–12 weeks after starting one. The test guide explains how to read the result.

The product link below goes to Amazon and we may earn a commission if you buy. It never changes which product we pick or what we say about it. How we choose.

Frequently asked questions

Related guides

• Vitamin D3 dosage guide — dose by blood-test result, the calculator, and the 1,000 vs 2,000 vs 5,000 IU debate
• Vitamin D for seniors — the 71+ RDA and why absorption, not the number, changes with age
• Vitamin D with or without K2
• The 25(OH)D test — how to read your result
• Vitamin D deficiency signs — symptoms, risk factors, drug interactions
• 1,000 vs 5,000 IU — maintenance versus correction
• Calcium dosage guide
• Iron for women
• Best vitamin D overall — every verified pick, ranked

Sources